Voriconazole metabolism is influenced by severe inflammation: a prospective study

Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children

(2016) Nienke J. Vet et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Comment on: Utility of voriconazole therapeutic drug monitoring: a meta-analysis: Table 1.

(2016) Anette Veringa et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology of severe sepsis: 2008-2012

(2016) Jeremy Stoller et al.   JOURNAL OF CRITICAL CARE

LC-MS/MS for Therapeutic Drug Monitoring of anti-infective drugs

(2016) Anette Veringa et al.   TRAC-TRENDS IN ANALYTICAL CHEMISTRY

Influence of Inflammation on Voriconazole Metabolism

(2015) M. A. Encalada Ventura et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review

(2015) Hazem Elewa et al.   CLINICAL PHARMACOKINETICS

Inflammation Is Associated with Voriconazole Trough Concentrations

(2014) Marjolijn J. P. van Wanrooy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections

(2014) Taotao Wang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Five year results of an international proficiency testing programme for measurement of antifungal drug concentrations

(2014) V. J. C. Lempers et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring

(2012) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial

(2012) Wan Beom Park et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole hepatotoxicity in severe liver dysfunction

(2012) Pablo Solís-Muñoz et al.   JOURNAL OF INFECTION

Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

(2011) SeungHwan Lee et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation

(2009) S. M. Trifilio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

(2009) Roger J. M. Brüggemann et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole Pharmacokinetics and Pharmacodynamics in Children

(2009) Michael Neely et al.   CLINICAL INFECTIOUS DISEASES

Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics

(2009) ET Morgan   CLINICAL PHARMACOLOGY & THERAPEUTICS

In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and Flavin-Containing Monooxygenase 3

(2009) S. B. Yanni et al.   DRUG METABOLISM AND DISPOSITION

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients

(2009) R. J. M. Bruggemann et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS

(2009) J.W.C. Alffenaar et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

(2008) E. T. Morgan et al.   DRUG METABOLISM AND DISPOSITION

The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers

(2008) Guo Wang et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole

(2008) Johanna Weiss et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES